financetom
Business
financetom
/
Business
/
Albemarle loses more than $1 billion in Q3 on falling lithium prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Albemarle loses more than $1 billion in Q3 on falling lithium prices
Nov 9, 2024 11:38 AM

Nov 6 (Reuters) - Albemarle, the world's largest

lithium producer, said on Thursday it lost more than $1 billion

in the third quarter and that it would slash its capital budget

amid a 71% drop in prices for the electric vehicle battery

metal.

The Charlotte, North Carolina-based company reported a net

loss of $1.11 billion, or $9.45 per share, compared to a net

profit of $302.5 million, or $2.57 per share, in the year-ago

quarter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Innovative Solutions & Support Fiscal Q4 Earnings, Sales Rise; Shares Gain After Hours
Innovative Solutions & Support Fiscal Q4 Earnings, Sales Rise; Shares Gain After Hours
Dec 19, 2024
05:09 PM EST, 12/19/2024 (MT Newswires) -- Innovative Solutions & Support (ISSC) reported fiscal Q4 earnings late Thursday of $0.18 per diluted share, up from $0.15 a year earlier. Two analysts polled by FactSet expected $0.16. Net sales in the three months ended Sept. 30 rose to $15.4 million from $13 million a year earlier. Two analysts surveyed by FactSet...
FirstEnergy Pennsylvania Unit Gets Regulatory Approval for Infrastructure Improvement Plans
FirstEnergy Pennsylvania Unit Gets Regulatory Approval for Infrastructure Improvement Plans
Dec 19, 2024
05:04 PM EST, 12/19/2024 (MT Newswires) -- FirstEnergy ( FE ) said Thursday that its FirstEnergy Pennsylvania unit obtained approval from the Pennsylvania Public Utility Commission to implement the third phase of its long-term infrastructure improvement plans. Under the plan, FirstEnergy Pennsylvania will invest an additional $1.42 billion over the next five years to decrease the frequency and shorten the...
US FDA approves Ionis Pharma's genetic disorder drug
US FDA approves Ionis Pharma's genetic disorder drug
Dec 19, 2024
Dec 19 (Reuters) - The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' ( IONS ) drug to treat a rare genetic disorder, making it the company's first wholly owned drug, the health regulator's website showed on Thursday. ...
Pyxis Oncology to Focus Resources on Lead Clinical Program PYX-201
Pyxis Oncology to Focus Resources on Lead Clinical Program PYX-201
Dec 19, 2024
05:05 PM EST, 12/19/2024 (MT Newswires) -- Pyxis Oncology ( PYXS ) said late Thursday it will focus its resources on advancing its lead clinical program, PYX-201, as part of its portfolio prioritization plan. The clinical-stage drugmaker said PYX-201 showed significant RECIST responses in head and neck squamous cell carcinoma as well as additional potential in other solid tumors. Pyxis...
Copyright 2023-2026 - www.financetom.com All Rights Reserved